Stomach Mucous Layer Disruption: Consequences for Digestive Health

The gastric mucus-bicarbonate barrier is the stomach’s first line of defense against autodigestion. Its disruption initiates a cascade of pathology.

Barrier Components

• Mucus gel layer: MUC5AC/MUC6 glycoproteins; viscous, adherent, 100–400 μm thick.
• Surface-active phospholipids: Hydrophobic monolayer at mucus-lumen interface.
• Bicarbonate gradient: Epithelial secretion creates pH 7 at surface vs. pH 1–2 in lumen.
• Epithelial restitution: Rapid migration of cells to seal defects.
• Prostaglandins (PGE₂/PGI₂): Stimulate mucus/bicarbonate, inhibit acid, maintain blood flow.

Consequences of Disruption

1. Gastritis (Acute & Chronic)

Direct acid/pepsin injury to epithelium → inflammation, erosions, hemorrhage. NSAIDs, alcohol, H. pylori, stress, bile reflux are major disruptors.

2. Peptic Ulcer Disease

Defect extending through muscularis mucosa. Duodenal > gastric. H. pylori + NSAIDs = synergistic risk. Complications: bleeding, perforation, obstruction.

3. Gastroesophageal Reflux Disease (GERD)

While primarily a lower esophageal sphincter (LES) disorder, impaired esophageal mucus clearance and gastric bile/acid reflux worsen mucosal injury.

4. Increased Infection Susceptibility

Mucus traps microbes; contains IgA, lactoferrin, defensins. Disruption → bacterial overgrowth, H. pylori colonization, enteric infections.

5. Nutrient Malabsorption

Severe gastritis/atrophy → loss of parietal cells (↓ intrinsic factor → B12 deficiency), chief cells (↓ pepsinogen), impaired iron/calcium absorption.

6. Autoimmune Gastritis

Anti-parietal cell antibodies → corpus-predominant atrophy → achlorhydria, hypergastrinemia, neuroendocrine hyperplasia, pernicious anemia. Link to barrier loss is complex.

Major Disruptors

Agent	Mechanism
NSAIDs/aspirin	COX-1 inhibition → ↓ prostaglandins; topical acid back-diffusion
Alcohol	Extracts phospholipids; disrupts tight junctions; ↑ acid
H. pylori	Urease → ammonia; proteases degrade mucus; inflammation
Stress (critical illness)	Splanchnic vasoconstriction → ischemia; ↓ mucus/bicarbonate
Bile reflux	Detergent action on phospholipid layer; activates proteases
Corticosteroids	Impair epithelial restitution; synergize with NSAIDs

Protection & Healing

• PPIs (reduce acid back-diffusion).
• Mucosal protectants: sucralfate, bismuth, rebamipide.
• H. pylori eradication (triple/quadruple therapy).
• NSAID minimization; co-therapy with PPI if NSAID essential.
• Adequate protein, zinc, vitamin A for epithelial repair.